drugset / Trial / NCT01223053

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

NCT01223053

Phase 3 Withdrawn Imprimis Pharmaceuticals, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Transdel Pharmaceuticals is investigating a topical cream formulation consisting of 10% ketoprofen for the local treatment of pain associated with mild to moderate acute soft tissue injury in this confirmatory Phase 3 trial.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketoprofen Small molecule 100 mg Topical

Indications

No indication recorded.